Common adverse effects include nausea, vomiting, diarrhea, and constipation, typically most pronounced during dose titration
For weight management , NICE technology appraisal guidance supports semaglutide 2.4 mg (Wegovy) for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 30 kg/m in exceptional circumstances), as part of a specialist weight management service
Firstly, how will it affect the services that L&H insurers can offer, especially risk prevention through earlier identification of diseases
Retatrutide is administered as a subcutaneous injection, typically once weekly
5 Its a useful option for people who havent responded enough to lifestyle changes alone
Return the vial to the fridge immediately after each draw short room-temperature exposure is normal during dosing, but long room-temperature storage is not